Pathology Doctors in Patterson, NJ Accepting Medicare
2 Pathology doctors found. Showing 1 - 2
 Dr. Meera Bodas, MD Pathology - Anatomic Pathology & Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: 680 Martin Luther King Jr Way, Patterson, NJ 07514 Phone: 973-977-6721 |
Dr. Qing Lin, MD Pathology - Anatomic Pathology & Clinical Pathology Medicare: Accepting Medicare Assignments Practice Location: 680 Martin Luther King Jr Way, Patterson, NJ 07514 Phone: 973-977-6721 |
News Archive
NIAID awards contracts to support early-stage human clinical trials of infectious disease treatments
The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has awarded contracts to three organizations to support early-stage human clinical trials of investigational infectious disease treatments. The new awards for the Phase I Clinical Trial Units for Therapeutics increases the number of funded organizations under the program from two to three, expanding capacity for conducting early safety testing of novel investigational drugs.
Researchers take new approach to understanding obstacles to breast cancer care in Appalachia
Researchers at the University of Virginia School of Medicine have taken a new approach to understanding why so many breast cancer patients in Appalachia aren't getting the care they need, and their findings are set to change how people view the obstacles to care that beset the region.
Zirmed achieves EHNAC HNAP accreditation
ZirMed®, a leading national provider of revenue cycle management solutions for healthcare providers, announced yesterday it has achieved full accreditation with the Healthcare Network Accreditation Program (HNAP) from the Electronic Healthcare Network Accreditation Commission (EHNAC). EHNAC's HNAP accreditation recognizes excellence in health data processing and transactions, and indicates compliance with industry-established standards and HIPAA regulations.
New test could prove to be quicker, cheaper way to diagnose respiratory viral illnesses
A new test that measures RNA or protein molecules in human cells can accurately identify viral infection as a cause of respiratory symptoms, according to a Yale study.
Investing in new hepatitis C therapies may have significant economic impact
While a new generation of safer, more effective oral medications to treat hepatitis C patients may cost tens of thousands of dollars for a 12-week regiment, investing in these new therapies could generate savings estimated at more than $3.2 billion annually in the U.S. and five European countries, according to a new study (abstract 228) released today at Digestive Disease Week® (DDW) 2015.
› Verified 3 days ago